SAG
MLAB icon

SageView Advisory Group’s Mesa Laboratories MLAB Stock Holding History

SageView Advisory Group’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30
Closed -$2.35K – 1712
2025
Q4 		$2.35K Buy
+30
New +$2.28K ﹤0.01% 2190

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

SageView Advisory Group's MLAB Position: Q1 2026 in Review

SageView Advisory Group sold out of Mesa Laboratories (MLAB) in Q1 2026, closing a stake of 30 shares — an estimated $2.35K sold.

SageView Advisory Group first reported a position in MLAB in Q4 2025 and held it in 1 quarter. The position peaked at $2.35K in Q4 2025. 161 funds tracked by Wall St. Rank hold MLAB as of Q1 2026.

  • SageView Advisory Group reported no remaining Mesa Laboratories position as of Q1 2026 after selling out during the quarter.
  • SageView Advisory Group sold 30 Mesa Laboratories shares in Q1 2026, an estimated $2.35K.
  • SageView Advisory Group first reported a position in Mesa Laboratories in Q4 2025 and held it in 1 quarter.
  • SageView Advisory Group's Mesa Laboratories position peaked at $2.35K in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.